These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27256282)

  • 1. From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment.
    Ramirez P; Lopez-Ferraz C; Gordon M; Gimeno A; Villarreal E; Ruiz J; Menendez R; Torres A
    Crit Care; 2016 Jun; 20(1):169. PubMed ID: 27256282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilated.
    Vallés J; Peredo R; Burgueño MJ; Rodrigues de Freitas AP; Millán S; Espasa M; Martín-Loeches I; Ferrer R; Suarez D; Artigas A
    Chest; 2013 May; 143(5):1219-1225. PubMed ID: 23715136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparision of risk factors and pathogens in patients with early- and late-onset ventilator-associated pneumonia in intensive care unit].
    Liang YJ; Li ZL; Wang L; Liu BY; Ding RY; Ma XC
    Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):743-746. PubMed ID: 29036955
    [No Abstract]   [Full Text] [Related]  

  • 4. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit.
    Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P
    Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study.
    Martin-Loeches I; Povoa P; Rodríguez A; Curcio D; Suarez D; Mira JP; Cordero ML; Lepecq R; Girault C; Candeias C; Seguin P; Paulino C; Messika J; Castro AG; Valles J; Coelho L; Rabello L; Lisboa T; Collins D; Torres A; Salluh J; Nseir S;
    Lancet Respir Med; 2015 Nov; 3(11):859-68. PubMed ID: 26472037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?
    Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S
    J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia.
    Nseir S; Martin-Loeches I; Makris D; Jaillette E; Karvouniaris M; Valles J; Zakynthinos E; Artigas A
    Crit Care; 2014 Jun; 18(3):R129. PubMed ID: 24958136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].
    Fekih Hassen M; Ayed S; Ben Sik Ali H; Gharbi R; Marghli S; Elatrous S
    Ann Fr Anesth Reanim; 2009 Jan; 28(1):16-23. PubMed ID: 19097848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study.
    Ramírez-Estrada S; Lagunes L; Peña-López Y; Vahedian-Azimi A; Nseir S; Arvaniti K; Bastug A; Totorika I; Oztoprak N; Bouadma L; Koulenti D; Rello J;
    Intensive Care Med; 2018 Aug; 44(8):1212-1220. PubMed ID: 30003304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative pneumonia following cardiac surgery in non-ventilated patients versus mechanically ventilated patients: is there any difference?
    Allou N; Allyn J; Snauwaert A; Welsch C; Lucet JC; Kortbaoui R; Desmard M; Augustin P; Montravers P
    Crit Care; 2015 Mar; 19(1):116. PubMed ID: 25881186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset.
    Vallés J; Pobo A; García-Esquirol O; Mariscal D; Real J; Fernández R
    Intensive Care Med; 2007 Aug; 33(8):1363-8. PubMed ID: 17558495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
    Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
    J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.
    Iregui M; Ward S; Sherman G; Fraser VJ; Kollef MH
    Chest; 2002 Jul; 122(1):262-8. PubMed ID: 12114368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.
    Chastre J; Wolff M; Fagon JY; Chevret S; Thomas F; Wermert D; Clementi E; Gonzalez J; Jusserand D; Asfar P; Perrin D; Fieux F; Aubas S;
    JAMA; 2003 Nov; 290(19):2588-98. PubMed ID: 14625336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
    McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
    J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.